New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›iShares›UMDV
UMDV

iShares US Medical Devices UCITS ETF

The UMDV Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: Dow Jones U.S. Select Medical Equipment Capped 35/20 Index. The UMDV ETF provides physical exposure, so by buying it you actually own parts of all the 49 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

$6.36
-$0.044 (-0.69%) today
8:00 AM 11/05/26 Closed
1D price range
$6.36$6.50
52W price range
$5.09$7.02
YTD Perf.
-4.32%
YTD Flows
Annualized volatility
Fund AuM
€282M
Share class AuM
€282M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE00BMX0DF60
TER
0.25%
Inception date
8/3/2020
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Nov 4, 2026
-25%-20%-15%-10%-5%0%JANMARMAYJULSEPNOV
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
99.77%
Unavailable
0.23%
Latest UMDV news

No content available for this fund

FAQ about UMDV

UMDV is a passively managed ETF that invests in the Disruptive Technology segment.
UMDV tracks the Dow Jones U.S. Select Medical Equipment Capped 35/20 NTR Index - USD, through a full replication replication method.
UMDV carries a total expense ratio (TER) of 0.25%.
UMDV was introduced to the market on August 3, 2020.
iShares US Medical Devices UCITS ETF, UMDV, is provided by iShares. Learn more about iShares here.
UMDV oversees €282M in assets as of November 4, 2026.
UMDV follows a capitalizing, meaning it reinvests income within the fund.
As of September 30, 2026, UMDV has significant geographic allocations in USA and Ireland.
As of September 30, 2026, UMDV focuses largely on Healthcare.
As of September 30, 2026, UMDV holds 49 positions in its portfolio, with 91.35% of assets concentrated in its top 15 holdings.
As of September 30, 2026, UMDV top three holdings include Abbott Laboratories, Intuitive Surgical, Inc. and Medtronic Plc.
The base currency of UMDV is USD.
Data as of 09/30/26
Abbott Laboratories
17.74%
Intuitive Surgical, Inc.
14.90%
Medtronic Plc
11.46%
Stryker Corp.
9.97%
Boston Scientific Corp.
6.56%
Edwards Lifesciences Corp.
5.16%
Becton, Dickinson & Co.
5.06%
IDEXX Laboratories, Inc.
4.27%
DexCom, Inc.
3.38%
ResMed, Inc.
3.31%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight